A polymorphism in the angiogenesis inhibitor, endostatin, in lung cancer susceptibility

被引：10
|
作者：
Zambon, Lair [1 ]
Honma, Helen N. [1 ]
Lourenco, Gustavo J. [2 ]
Saad, Ivete A. B. [1 ]
Mussi, Ricardo K. [1 ]
Lima, Carmen S. P. [2 ]
机构：
[1] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Pulm Unit, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Clin Oncol Serv, Campinas, SP, Brazil
来源：
LUNG CANCER | 2008年 / 59卷 / 02期
关键词：
lung cancer; endostatin; D104N polymorphism; susceptibility;
D O I：
10.1016/j.lungcan.2007.10.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：276 / 278
页数：3
相关论文
共 50 条
  • [21] Endostatin, an Inhibitor of Angiogenesis, Decreases After Bidirectional Superior Cavopulmonary Anastamosis
    Aida Field-Ridley
    Ritva Heljasvaara
    Taina Pihlajaniemi
    Ian Adatia
    Christine Sun
    Roberta L. Keller
    Wen Hui Gong
    Sanjeev Datar
    Peter Oishi
    Jeffrey R. Fineman
    Pediatric Cardiology, 2013, 34 : 291 - 295
  • [22] Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls
    Miosge, N
    Sasaki, T
    Timpl, R
    FASEB JOURNAL, 1999, 13 (13): : 1743 - 1750
  • [23] Serum level of the circulating angiogenesis inhibitor endostatin in patients with hyperthyroidism or hypothyroidism
    Kucharz, EJ
    Kotulska, A
    Kopec, M
    Stawiarska-Pieta, B
    Pieczyrak, R
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (5-6) : 179 - 181
  • [24] The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing
    Berger, AC
    Feldman, AL
    Gnant, MFX
    Kruger, EA
    Sim, BKL
    Hewitt, S
    Figg, WD
    Alexander, HR
    Libutti, SK
    JOURNAL OF SURGICAL RESEARCH, 2000, 91 (01) : 26 - 31
  • [25] Endostatin, an Inhibitor of Angiogenesis, Decreases After Bidirectional Superior Cavopulmonary Anastamosis
    Field-Ridley, Aida
    Heljasvaara, Ritva
    Pihlajaniemi, Taina
    Adatia, Ian
    Sun, Christine
    Keller, Roberta L.
    Gong, Wen Hui
    Datar, Sanjeev
    Oishi, Peter
    Fineman, Jeffrey R.
    PEDIATRIC CARDIOLOGY, 2013, 34 (02) : 291 - 295
  • [26] Polymorphism of the DNA repair gene XPA and susceptibility to lung cancer
    Jinfu Zhu~1
    ~2Department of Epidemiology & Biostatistics
    ~3Department of Thoracic Surgery
    JournalofNanjingMedicalUniversity, 2005, (04) : 173 - 176
  • [27] Lung cancer susceptibility: A CDKN1A promoter polymorphism enhances the risk for lung cancer
    Field, J
    Xinarianos, G
    Myles, J
    Nikolaidis, G
    Cassidy, A
    Duffy, S
    Liloglou, T
    LUNG CANCER, 2005, 49 : S82 - S82
  • [28] Angiogenesis Inhibition Using an Oncolytic Herpes Simplex Virus Expressing Endostatin in a Murine Lung Cancer Model
    Goodwin, Jonathan M.
    Schmitt, Anthony D.
    McGinn, Christopher M.
    Fuchs, Bryan C.
    Kuruppu, Darshini
    Tanabe, Kenneth K.
    Lanuti, Michael
    CANCER INVESTIGATION, 2012, 30 (03) : 243 - 250
  • [29] Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy:: Selective inhibitor of angiogenesis and hypoxic tumor growth
    Li, X
    Fu, GF
    Fan, YR
    Liu, WH
    Liu, XJ
    Wang, JJ
    Xu, GX
    CANCER GENE THERAPY, 2003, 10 (02) : 105 - 111
  • [30] Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growth
    Xi Li
    Geng-Feng Fu
    Yan-Rong Fan
    Wen-Hua Liu
    Xin-Juan Liu
    Jian-Jun Wang
    Gen-Xing Xu
    Cancer Gene Therapy, 2003, 10 : 105 - 111
12345